BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 15837750)

  • 1. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
    Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
    Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical validation of a monochrome real-time multiplex assay for translocations in childhood acute lymphoblastic leukemia.
    Siraj AK; Ozbek U; Sazawal S; Sirma S; Timson G; Al-Nasser A; Bhargava M; El Solh H; Bhatia K; Gutiérrez MI
    Clin Cancer Res; 2002 Dec; 8(12):3832-40. PubMed ID: 12473597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
    Seeger K; Kreuzer KA; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt CA; Henze G
    Cancer Res; 2001 Mar; 61(6):2517-22. PubMed ID: 11289124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of TEL proteins in human leukemias.
    Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
    Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the childhood acute lymphoblastic leukemia with t(12;21)].
    Lin D; Liu SH; Zhu XF; Bo LJ; Li CW; Chen YM; Liu XP; Qin S; Dai Y; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):17-21. PubMed ID: 14990071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
    Asakura K; Uchida H; Miyachi H; Kobayashi H; Miyakawa Y; Nimer SD; Takahashi H; Ikeda Y; Kizaki M
    Mol Cancer Res; 2004 Jun; 2(6):339-47. PubMed ID: 15235109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies].
    Zuna J
    Cas Lek Cesk; 2001 Mar; 140(5):131-7. PubMed ID: 11347199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
    Ramakers-van Woerden NL; Pieters R; Loonen AH; Hubeek I; van Drunen E; Beverloo HB; Slater RM; Harbott J; Seyfarth J; van Wering ER; Hählen K; Schmiegelow K; Janka-Schaub GE; Veerman AJ
    Blood; 2000 Aug; 96(3):1094-9. PubMed ID: 10910927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.
    Stams WA; Beverloo HB; den Boer ML; de Menezes RX; Stigter RL; van Drunen E; Ramakers-van-Woerden NL; Loonen AH; van Wering ER; Janka-Schaub GE; Pieters R
    Leukemia; 2006 Mar; 20(3):410-6. PubMed ID: 16424874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions.
    Al-Sweedan SA; Neglia JP; Steiner ME; Bostrom BC; Casey T; Hirsch BA
    Pediatr Blood Cancer; 2007 May; 48(5):510-4. PubMed ID: 16763978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of TEL-AML1 fusion gene in childhood B-lineage acute lymphoblastic leukemia].
    Niu C; Huang W; Su X
    Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):61-4. PubMed ID: 11601199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of TEL/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukemia.
    Zen PR; Lima MC; Coser VM; Silla L; Daudt L; Fernandes MS; Neumann J; Mattevi MS; Ortigara R; Paskulin GA
    Cancer Genet Cytogenet; 2004 May; 151(1):68-72. PubMed ID: 15120912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
    Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
    Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization.
    Tsuzuki S; Karnan S; Horibe K; Matsumoto K; Kato K; Inukai T; Goi K; Sugita K; Nakazawa S; Kasugai Y; Ueda R; Seto M
    Cancer Sci; 2007 May; 98(5):698-706. PubMed ID: 17374122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.
    Shih LY; Chou TB; Liang DC; Tzeng YS; Rubnitz JE; Downing JR; Pui CH
    Leukemia; 1996 Sep; 10(9):1456-8. PubMed ID: 8751462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.